Nokia Posts Decline in First-Quarter Sales, Sees Lower Earnings
Posted on: Tuesday, 6 April 2004, 06:00 CDT
Apr. 7--Nokia, the world's biggest cellphone maker, missed the public's growing fondness for folding, clamshell-style cellphones in the first quarter and paid for it in lower earnings.
In response, investors pummeled the company's stock Tuesday on the New York Stock Exchange, knocking its price down $3.94, or nearly 19 percent, to $17.21 a share. Trading was about nine times normal daily volume.
Nokia, based in Finland said its first-quarter sales were down 2 percent, at odds with the company's forecast in January of sales gains of 3 percent to 7 percent. First-quarter net profit of 17 cents per share of common stock was down from 21 cents a year earlier and well short of Wall Street's expectation of 24 cents a share.
"It's a stumble for the quarter. But I don't think the sky is falling," said Ren Zamora, who follows Nokia for Loop Capital Markets in Chicago. "There were a lot of high expectations, and now that you've let some air out of the balloon, they're getting punished."
Before Tuesday, the stock price had been up nearly 27 percent this year. Despite the shortfall, Nokia said it sold about 19 percent more cellphones than during the same quarter last year, but the industry overall had about 25 percent growth.
Nokia employs about 1,200 at its Alliance Airport area distribution center, and its headquarters for the Americas is in Irving. Spokesman Keith Nowak said, "There isn't really any impact" on local employment as a result of the first-quarter results.
According to a recent Gartner Group survey, Nokia makes about 35 percent of the world's cellphones, more than double No. 2 Motorola. Some Wall Street analysts said the first-quarter glitch trimmed as much as 4 percentage points off that market share, which the company hotly disputed without offering an estimate.
"I figure they did lose a couple of percentage points," Zamora said. Cellphones account for about 80 percent of Nokia's revenues, which totaled $7.9 billion in the first quarter.
In a conference call with investment analysts, Nokia Chairman Jorma Ollila acknowledged that the company was particularly uncompetitive in meeting demand for new clamshell phones. But he noted that the company introduced seven phone models in the first quarter and should introduce 40 this year.
Ollila also said revenues in Nokia's unit that makes cellphone base stations were higher than expected at $1.7 billion, with strong profit margins. Another unit that makes phones for corporate use also did better than expected.
The company said it will report its complete first-quarter earnings April 16, when it will also offer a second-quarter outlook.
Chris Bulkey, who follows the company for Technology Research Group in Westchester, Pa., said that with about $14.6 billion in cash and securities on its balance sheet, Nokia can weather this storm.
"Nokia had a little warning, but they're strong," Bulkey said. He said the company has generally been conservative in its earnings reporting and management's credibility shouldn't suffer too much because of a disappointing quarter.
-----
To see more of the Fort Worth Star-Telegram, or to subscribe to the newspaper, go to http://www.dfw.com
(c) 2004, Fort Worth Star-Telegram, Texas. Distributed by Knight Ridder/Tribune Business News.
NOK, MOT, IT,
Related Articles
- Progress Energy Announces 2009 First-Quarter Results; On Track for Full-Year 2009 Earnings Guidance
- Surveyed Neurologists in Both the United States and Europe Indicate That a Once-Daily Transdermal Formulation of Levodopa Would Earn a 30 Percent Patient Share in Parkinson's Disease
- A Drug That Improves Exercise Capacity By a Greater Percentage Than Tracleer Would Earn a 48 Percent Patient Share in the Pulmonary Arterial Hypertension Market
- A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
- A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market
- AstraZeneca's Recentin Plus FOLFOX4 to Earn 10 Percent Patient Share in the Treatment of Colorectal Cancer By 2016
- AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer By 2016
- CenterPoint Energy Raises Quarterly Dividend 7 Percent; Dividend Increases From 17 Cents to 18.25 Cents Per Share
- Cimarex Energy Announces Commencement of a Quarterly Dividend, Authorization for a Common Stock Repurchase Program and Updated 2006 Capital Guidance
- Nokia Q1 Market Share Falls to 29%
User Comments (0)

RSS Feeds